| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vascular Biogenics Ltd (NASDAQ: VBLT)
VBLT Technical Analysis
5
| As on 9th Jun 2023 VBLT STOCK Price closed @ 0.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.04 & Strong Sell for SHORT-TERM with Stoploss of 1.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VBLTSTOCK Price
| Open | 0.26 | Change | Price | % |
| High | 0.26 | 1 Day | -0.01 | -4.00 |
| Low | 0.22 | 1 Week | 0.03 | 14.29 |
| Close | 0.24 | 1 Month | 0.06 | 33.33 |
| Volume | 2412400 | 1 Year | -1.83 | -88.41 |
| 52 Week High 2.10 | 52 Week Low 0.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VBLT Daily Charts |
VBLT Intraday Charts |
Whats New @ Bazaartrend |
VBLT Free Analysis |
|
|
VBLT Important Levels Intraday
| RESISTANCE | 0.32 |
| RESISTANCE | 0.29 |
| RESISTANCE | 0.28 |
| RESISTANCE | 0.26 |
| SUPPORT | 0.22 |
| SUPPORT | 0.20 |
| SUPPORT | 0.19 |
| SUPPORT | 0.16 |
VBLT Forecast May 2024
| 4th UP Forecast | 1.67 |
| 3rd UP Forecast | 1.21 |
| 2nd UP Forecast | 0.93 |
| 1st UP Forecast | 0.64 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.45 |
| 3rd DOWN Forecast | -0.73 |
| 4th DOWN Forecast | -1.19 |
VBLT Weekly Forecast
| 4th UP Forecast | 0.72 |
| 3rd UP Forecast | 0.57 |
| 2nd UP Forecast | 0.47 |
| 1st UP Forecast | 0.38 |
| 1st DOWN Forecast | 0.10 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.09 |
| 4th DOWN Forecast | -0.24 |
VBLT Forecast2024
| 4th UP Forecast | 4.29 |
| 3rd UP Forecast | 2.99 |
| 2nd UP Forecast | 2.19 |
| 1st UP Forecast | 1.38 |
| 1st DOWN Forecast | -0.9 |
| 2nd DOWN Forecast | -1.71 |
| 3rd DOWN Forecast | -2.51 |
| 4th DOWN Forecast | -3.81 |
Vascular Biogenics Ltd ( NASDAQ USA Symbol : VBLT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VBLT Business Profile
Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer and immune/inflammatory indications in Israel and the United States. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes genetically targeted therapy to destroy newly formed or angiogenic blood vessels. Its lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-511, an anti-angiogenic candidate for oncology; VB-211 and VB-411, which are pro-angiogenic candidates for the treatment of peripheral vascular diseases; and VB-703 for NASH and renal fibrosis. In addition, the company is developing VB-201, a Lecinoxoid-based product candidate to treat atherosclerosis that has completed Phase II clinical; and is in Phase II exploratory trials for COVID-19, as well as in pre-clinical stage for the treatment of NASH and renal fibrosis. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel. Address: 8 HaSatat Street, Hevel Modi'in, Israel, 7178106
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service